Teva Announces FDA Approval of Ajovy (fremanezumab-vfrm) Injection Autoinjector

Article Link: Teva Announces FDA Approval of Ajovy (fremanezumab-vfrm) Injection Autoinjector

PARSIPPANY, N.J.–(BUSINESS WIRE) January 28, 2020 — Teva Pharmaceuticals USA, Inc. an affiliate ofTeva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the Food and Drug Administration (FDA) has approved an autoinjector…

Source: FDA New Drug Approvals